feed,title,long_url,short_url
SeekingAlpha,JP Morgan cuts Humanigen to underweight on FDA lenzilumab EUA rejection; shares drop 50%,https://seekingalpha.com/news/3738370,
SeekingAlpha,Exploring Alternatives To The U.S. 60/40 Benchmark: Part I,https://seekingalpha.com/article/4454257,
